Blocking an enzyme could put a stop to the buildup of toxic protein clumps that occurs in the brains of people with Parkinson's disease.

This was the conclusion that scientists at Georgetown University Medical Center (GUMC) in Washington, D.C. reached after studying the enzyme, called USP13, in the brains of mice and humans.